Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome

Dyslipidemia and metabolic abnormalities are strongly associated with atherosclerosis and worse cardiovascular outcomes

Sundararajan Srikanth

2016

Scholarcy highlights

  • Dyslipidemia and metabolic abnormalities are strongly associated with atherosclerosis and worse cardiovascular outcomes
  • While pharmacotherapy with statins has been proven to be beneficial for dyslipidemia, lifestyle modification emphasizing weight loss and regular exercise is an essential component of the interventional strategy
  • Improved understanding of the role of endothelium in health and disease can potentially lead to novel therapies that may preempt development of atherosclerosis and its complications
  • The International Atherosclerosis Society has developed a new set of recommendations for the management of dyslipidemia
  • Current evidence based guidelines for management of hyperlipidemia from ACC/AHA

Need more features? Save interactive summary cards to your Scholarcy Library.